Dr. Terrence Cescon
Claim this profileReading Hospital
Expert in Skin Cancer
Expert in Stomach Cancer
68 reported clinical trials
128 drugs studied
About Terrence Cescon
Education:
- Obtained MD from Drexel University College of Medicine in 2015.
- Completed Residency in Internal Medicine at Reading Hospital, serving as Chief Resident (2018-2019).
- Finished Fellowship in Hematology/Oncology at Fox Chase Cancer Center in 2022.
Experience:
- Specializes in Hematology/Oncology with comprehensive training and experience based in Pennsylvania, United States.
Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Stomach Cancer
Global LeaderStage IV
Stage III
HER2 negative
Affiliated Hospitals
Clinical Trials Terrence Cescon is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting2 awards Phase 32 criteria
More about Terrence Cescon
Clinical Trial Related1 year of experience running clinical trials · Led 68 trials as a Principal Investigator · 31 Active Clinical TrialsTreatments Terrence Cescon has experience with
- Nivolumab
- Paclitaxel
- Fluorouracil
- Biospecimen Collection
- Carboplatin
- Pembrolizumab
Breakdown of trials Terrence Cescon has run
Skin Cancer
Stomach Cancer
Breast Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Terrence Cescon specialize in?
Terrence Cescon focuses on Skin Cancer and Stomach Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Terrence Cescon currently recruiting for clinical trials?
Yes, Terrence Cescon is currently recruiting for 28 clinical trials in West Reading Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Terrence Cescon has studied deeply?
Yes, Terrence Cescon has studied treatments such as Nivolumab, Paclitaxel, Fluorouracil.
What is the best way to schedule an appointment with Terrence Cescon?
Apply for one of the trials that Terrence Cescon is conducting.
What is the office address of Terrence Cescon?
The office of Terrence Cescon is located at: Reading Hospital, West Reading, Pennsylvania 19611 United States. This is the address for their practice at the Reading Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.